Skip to main content

Table 3 Pooled hazard ratio for cardiovascular mortality in patients receiving vitamin D or no treatment

From: Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies

Patient groups

# patients

Hazard ratio

# studies

I2, %

Crude cardiovascular mortality using baseline Cox model

    

 Alfacalcitol vs no treatment

432

0.37 (0.25–0.55)

2

0

 Calcitrol vs no treatment

1889

0.57 (0.46–0.71)

1

NA

 Paricalcitol vs no treatment

1230

0.31 (0.22–0.44)

1

NA

 Overall

3551

0.41 (0.28–0.59)

4

69.9

Adjusted cardiovascular mortality using baseline Cox model

    

 Any vitamin D vs no treatment

466

0.59 (0.19–1.82)

2

68.6

 Alfacalcitol vs no treatment

665

0.45 (0.14–1.47)

1

NA

 Calcitrol vs no treatment

1889

0.63 (0.50–0.79)

1

NA

 Paricalcitol vs no treatment

1230

0.43 (0.29–0.63)

1

NA

 Overall

4250

0.59 (0.41–0.86)

5

83.6